CN110892962A - Solid granules containing procyanidine - Google Patents
Solid granules containing procyanidine Download PDFInfo
- Publication number
- CN110892962A CN110892962A CN201910978065.6A CN201910978065A CN110892962A CN 110892962 A CN110892962 A CN 110892962A CN 201910978065 A CN201910978065 A CN 201910978065A CN 110892962 A CN110892962 A CN 110892962A
- Authority
- CN
- China
- Prior art keywords
- parts
- spirulina
- inulin
- following components
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 21
- 239000007787 solid Substances 0.000 title claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 15
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 13
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 13
- 241001593968 Vitis palmata Species 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 13
- 229940029339 inulin Drugs 0.000 claims abstract description 13
- 229940082787 spirulina Drugs 0.000 claims abstract description 13
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims abstract description 10
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims abstract description 10
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims abstract description 10
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920002414 procyanidin Polymers 0.000 claims abstract description 10
- 239000003973 paint Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 5
- 241000210711 Partulina Species 0.000 abstract description 2
- 208000014617 hemorrhoid Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 208000014951 hematologic disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses procyanidine-containing solid granules which comprise the following components in parts by weight: inulin 4-8 parts, red grape fruit powder (containing procyanidin above 95%) 0.1-0.4 part, and Spirulina 0.05-0.5 part. The invention can treat hemorrhoidal disease with obvious treatment effect, and solves the problems in the prior art.
Description
Technical Field
The invention relates to solid granules, in particular to solid granules containing procyanidine, and belongs to the technical field of functional foods.
Background
With the age of people, partial functions of the body of people are reduced to different degrees, so that old people are easy to have hemiplegia or suffer from blood diseases such as high cholesterol, high blood pressure, high blood fat and the like due to diet problems.
For the blood diseases, the existing treatment methods are all treated by western medicines, but the western medicines have large toxic and side effects, have different degrees of damage to human bodies and cannot be used for a long time.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide the solid granules containing the procyanidine, which can treat the human blood diseases.
In order to solve the problems, the invention adopts the following technical scheme: a solid instant granule containing procyanidine comprises the following components in parts by weight: 4-8 parts of inulin, 0.1-0.4 part of red grape fruit powder and 0.05-0.5 part of spirulina.
The following is a further optimization of the present invention to the above scheme: a solid instant granule containing procyanidine comprises the following components in parts by weight: 4 parts of inulin, 0.2 part of red grape fruit powder and 0.05 part of spirulina.
Further optimization: a solid instant granule containing procyanidine comprises the following components in parts by weight: 5 parts of inulin, 0.3 part of red grape fruit powder and 0.06 part of spirulina.
Further optimization: a solid instant granule containing procyanidine comprises the following components in parts by weight: 6 parts of inulin, 0.4 part of red grape fruit powder and 0.5 part of spirulina.
Further optimization: a solid granule containing procyanidin is in the form of powder.
The present invention solves the technical problems mentioned in the background art.
The present invention will be further described with reference to the following examples.
Detailed Description
Embodiment 1, a solid granule containing procyanidin comprises the following components in parts by weight: inulin 4 parts, red grape fruit powder 0.1 part and spirulina 0.05 part.
The inulin is fructo-oligosaccharide extracted from jerusalem artichoke, belongs to soluble dietary fiber, and has good effects of regulating intestinal microbial flora of human body and improving intestinal health.
The red grape fruit powder is grape seed extract grape polyphenol, grape seeds contain rich procyanidine, have strong antioxidation, are known as natural skin care products, can resist oxidation and allergy, delay skin aging, and have the effects of inhibiting platelet aggregation and atherosclerosis formation.
The spirulina is rich in high-quality protein, fatty acid of gamma-linolenic acid, carotenoid, vitamins, and various trace elements such as ferrum, iodine, selenium, zinc, etc.
Embodiment 2, a solid granule containing procyanidin comprises the following components in parts by weight: 6 parts of inulin, 0.25 part of red grape fruit powder and 0.3 part of spirulina.
Embodiment 3, a solid granule containing procyanidin comprises the following components in parts by weight: 8 parts of inulin, 0.4 part of red grape fruit powder and 0.5 part of spirulina.
Case (2):
1. before administration, the patients had age spots due to pigmentation in hands, arms and faces, and gradually faded and disappeared after taking the formula for one and a half years at the dose of 5 g/day until the age spots on the hands, arms and faces of the patients disappeared in 6 months of 2018;
2. liu's, woman, 55 years old, 2016 6 th day check have three highs (high blood fat, high cholesterol, high blood pressure), the doctor recommends that the patient take statins and aspirin to treat, after the patient has taken oral granule for several days, the patient uses the formulation to 5g per day, after taking continuously for 3 months, go to hospital to check blood, the blood index is normal, still taking continuously so far;
ninety percent of white hair was completely absent in both patients except for the recovery of the symptoms;
3. flare, female, age 94, stroke in 1990, symptoms: the hands and feet are numb, the limbs are weak, the self-care function cannot be realized, the intravenous injection treatment is required for 15 days from spring to winter every year, the formula is taken from 2012, the quantity of the formula is 5 g/day, the hands and the feet are not numb after the product is taken for half a year, the self-care function can be realized, the product is continuously taken from 2013 to the present, the liquid is not transfused, the state is good, and the white cell index is normal;
in conclusion, the traditional Chinese medicine composition has obvious treatment effect and can treat the blood liquid diseases.
Having shown and described the basic principles and essential features of the invention and its advantages, it will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof, and it is therefore intended that the embodiments be considered as illustrative and not restrictive in all respects, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (5)
1. A solid granule containing procyanidin is characterized in that: the paint comprises the following components in parts by weight: 4-8 parts of inulin, 0.1-0.4 part of red grape fruit powder and 0.05-0.5 part of spirulina.
2. A solid granule containing procyanidin is characterized in that: the paint comprises the following components in parts by weight: 4 parts of inulin, 0.2 part of red grape fruit powder and 0.05 part of spirulina.
3. A solid granule containing procyanidin is characterized in that: the paint comprises the following components in parts by weight: 5 parts of inulin, 0.3 part of red grape fruit powder and 0.06 part of spirulina.
4. A solid granule containing procyanidin is characterized in that: the paint comprises the following components in parts by weight: 6 parts of inulin, 0.4 part of red grape fruit powder and 0.5 part of spirulina.
5. A procyanidin-containing solid granules as claimed in any one of claims 1 to 4, which is characterized in that: the solid granule is in powder form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910978065.6A CN110892962A (en) | 2019-10-15 | 2019-10-15 | Solid granules containing procyanidine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910978065.6A CN110892962A (en) | 2019-10-15 | 2019-10-15 | Solid granules containing procyanidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110892962A true CN110892962A (en) | 2020-03-20 |
Family
ID=69786156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910978065.6A Pending CN110892962A (en) | 2019-10-15 | 2019-10-15 | Solid granules containing procyanidine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110892962A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111296728A (en) * | 2020-04-10 | 2020-06-19 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103125808A (en) * | 2013-03-21 | 2013-06-05 | 祖廷勋 | Antioxidant composite tablet for beauty and preparation method thereof |
| CN103156107A (en) * | 2013-03-21 | 2013-06-19 | 祖廷勋 | Inulin-spirulina compound tablet and preparation method thereof |
| CN106473114A (en) * | 2015-08-24 | 2017-03-08 | 广州硕维食品技术有限公司 | A kind of anti-apolexis composition |
| CN108056356A (en) * | 2018-02-02 | 2018-05-22 | 云南瑞宝生物科技股份有限公司 | A kind of anthocyanidin solid beverage containing inulin and preparation method thereof |
-
2019
- 2019-10-15 CN CN201910978065.6A patent/CN110892962A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103125808A (en) * | 2013-03-21 | 2013-06-05 | 祖廷勋 | Antioxidant composite tablet for beauty and preparation method thereof |
| CN103156107A (en) * | 2013-03-21 | 2013-06-19 | 祖廷勋 | Inulin-spirulina compound tablet and preparation method thereof |
| CN106473114A (en) * | 2015-08-24 | 2017-03-08 | 广州硕维食品技术有限公司 | A kind of anti-apolexis composition |
| CN108056356A (en) * | 2018-02-02 | 2018-05-22 | 云南瑞宝生物科技股份有限公司 | A kind of anthocyanidin solid beverage containing inulin and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 白鸿: "《保健食品功效成分检测方法》", 31 May 2011, 中国中医药出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111296728A (en) * | 2020-04-10 | 2020-06-19 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
| CN111296728B (en) * | 2020-04-10 | 2023-03-07 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
| CN102742656B (en) | Milky tea relieving asthenopia and preparation method thereof | |
| CN101296693A (en) | Endurance improver | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN104432036A (en) | Health care nutrition composition capable of relieving asthenopia as well as preparation method and application thereof | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN101108227A (en) | Konjak extractive powder capsule | |
| CN111329907A (en) | Common turnip composition with anti-hypoxia function and preparation method and application thereof | |
| CN110892962A (en) | Solid granules containing procyanidine | |
| CN101999668B (en) | Composition for treating diabetes mellitus | |
| CN104000216A (en) | Prebiotics water-soluble dietary fiber and preparation method thereof | |
| CN101120750B (en) | Method for preparing ginkgo bee product | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN105166620A (en) | Horseradish tree composition capable of reducing blood lipid and preparation method of horseradish tree composition | |
| KR101808944B1 (en) | Composition for preventing and treating dysmenorrhea and premature labor comprising non-polar solvent subfraction from Zingiber officinale extract | |
| WO2010075611A1 (en) | Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance | |
| KR20050101143A (en) | Methods and composition for the prevention and improvement of degenerative arthritis including glucosamin | |
| CN106924438A (en) | A kind of black fruit fructus lycii syrup and its preparation technology with alleviation visual fatigue | |
| CN103169125B (en) | A kind of nutrition type beverage and preparation method thereof | |
| Srivastava et al. | Nutraceutical Potential of pumpkin (Cucurbita sp.) powder, seed, extracts, and oil on diabetes; Mini Review | |
| KR20010079241A (en) | Composition for Restorative herb medicine and manufacturing method of Restorative herb medicine | |
| CN110859912A (en) | Traditional Chinese medicine composition for prostatitis and preparation method and application thereof | |
| CN103271172A (en) | Health-care blending corn oil and preparation method thereof | |
| CN103082299A (en) | Nutritional healthcare product for clearing bowels and expelling toxin | |
| CN111686236B (en) | Capsule for dispelling effects of alcohol, protecting liver and protecting brain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200320 |